SEC Form 4 · accession 0001144204-17-044479
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bendheim
Officer — Exec. VP, Corporate Strategy · Director
Period of report
Aug 17, 2017
Accepted (ET)
Aug 21, 2017 · 9:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 17, 2017 | M | 4,176 | $11.83 | A | 4,176 | D | |
| Class A Common StockF2 | Aug 17, 2017 | S | 4,176 | $40.01 | D | 0 | D | |
| Class A Common Stock | Aug 21, 2017 | M | 800 | $11.83 | A | 800 | D | |
| Class A Common StockF3 | Aug 21, 2017 | S | 800 | $40.02 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Aug 17, 2017 | M | 4,176 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 4,176 | 27,923 | D |
| Option to purchase Common Stock | $11.83 | Aug 21, 2017 | M | 800 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 800 | 27,123 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive.